Neurocognitive deficits following primary brain tumor treatment: systematic review of a decade of comparative studies Amanda K. GehrkeMargaret C. BaisleyMichael Feuerstein Topic Review 23 August 2013 Pages: 135 - 142
MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas Omer Faruk BayrakSukru GulluogluMustafa Ozen Laboratory Investigation 03 August 2013 Pages: 143 - 151
Trends in childhood brain tumor incidence, 1973–2009 Roberta McKean-CowdinPedram RazaviSusan Preston-Martin Laboratory Investigation 08 August 2013 Pages: 153 - 160
Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma Melanie G. Hayden GephartYouRong Sophie SuMatthew P. Scott Laboratory Investigation 12 September 2013 Pages: 161 - 168
The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells Takuro HayashiKazuhide AdachiYuichi Hirose Laboratory Investigation 13 August 2013 Pages: 169 - 178
MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis Yue-chao FanPeng-jin MeiZhong-lin Li Laboratory Investigation 13 August 2013 Pages: 179 - 188
An in vivo mouse model of intraosseous spinal cancer causing evolving paraplegia Davina A. F. CossignyEffie MouhtourisGerald M. Y. Quan Laboratory Investigation 18 August 2013 Pages: 189 - 196
MR-based hypoxia measures in human glioma Vivien TóthAnnette FörschlerChristine Preibisch Clinical Study 07 August 2013 Pages: 197 - 207
Relapse patterns in pediatric embryonal central nervous system tumors Sébastien PerreaultRobert M. LoberSonia Partap Clinical Study 07 August 2013 Pages: 209 - 215
Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery Christopher P. DeibertManmeet S. AhluwaliaDouglas Kondziolka Clinical Study 09 August 2013 Pages: 217 - 223
Chronic epilepsy due to low grade temporal lobe tumors and due to hippocampal sclerosis: Do they differ in post-surgical outcome? Prasad S. S. V. VannemreddyAndres M. KannerRichard W. Byrne Clinical Study 17 August 2013 Pages: 225 - 231
5,10-Methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTRR), and methionine synthase reductase (MTR) gene polymorphisms and adult meningioma risk Jun ZhangYan-Wen ZhouXin-You Xie Clinical Study 20 August 2013 Pages: 233 - 239
The role of adjuvant radiotherapy in atypical meningioma Hae Jin ParkHyun-Cheol KangHee-Won Jung Clinical Study 15 August 2013 Pages: 241 - 247
cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome Yazmin OdiaBrent A. OrrFausto J. Rodriguez Clinical Study 11 August 2013 Pages: 249 - 259
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy F. DucrayG. KaloshiJean-Yves Delattre Clinical Study 17 August 2013 Pages: 261 - 265
Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival Christina ChenRaymond HuangAndrew D. Norden Clinical Study 22 August 2013 Pages: 267 - 276
Institutional charges and disparities in outpatient brain biopsies in four US States: The State Ambulatory Database (SASD) Kimon BekelisSymeon MissiosDavid W. Roberts Clinical Study 20 August 2013 Pages: 277 - 283
Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients Chunxia DuRuoxi HongJinwan Wang Clinical Study 03 September 2013 Pages: 285 - 291
Pregnancy in women with gliomas: a case-series and review of the literature Hanneke ZwinkelsJoep DörrCharles J. Vecht Clinical Study 25 August 2013 Pages: 293 - 301
Glioblastoma management in the temozolomide era: have we improved outcome? Zarnie LwinDerek MacFaddenWarren P. Mason Clinical Study 25 August 2013 Pages: 303 - 310
Industry progress report on neuro-oncology: Biotech update 2013 Malte OttenhausenImithri BodhinayakeJohn A. Boockvar Meeting Proceedings 16 August 2013 Pages: 311 - 316